Abstract:Background: Angiotensin II (Ang II) can induce cardiac hypertrophy and platelet-derived growth factor(PDGF) also stimulates cardiac hypertrophy. Is AngII responsible for the pathogenesis of cardiac hypertrophy by inducing PDGF receptor expression? Objective: To investigate the effect of mitogen activated protein kinase (MAPK) on the role of cardiac hypertrophy induced by Ang II in cardiac myocytes so as to provide theoretical basis for clinical prevention and cure of cardiac hypertrophy. Design: Controlled experimental study taking cardiac myocytes of cultured neonatal rats as subjects. Setting: Department of pathophysiology in a university. Materials: The experiment was completed in the Department of Pathophysiology, Medical College of Peking University. A total of 80 Wistar rats of either gender, aged 1-3 days, were provided by the Animal Center of Medical College, Peking University. Their hearts were removed for myocyte culture in the Cell Culture Laboratory. Interventions: The cultured neonatal rat cardiac myocytes treated with 10-7mol/L Ang II were Ang II group, and those preincubated with 10-5mol/L PD98059 (an antagonist of MAPK) for 30 minutes and then treated with Ang II were PD98059 group. Cardiac myocytes of normal neonatal rats were as control group. The expression of PDGF-β was detected by western blot at 24 hours. Main outcome measures: Content of PDGF-β receptor in neonatal rat cardiac myocytes. Results: The expression of PDGF-β receptor induced by Ang II at neonatal rat cardiac myocytes markedly increased at 24 hours (432.41 ±54.08) compared with that of control group (197.65±44.10) (q=6.77, P < 0.01). PDGF-β receptor expression of PD98059 group(317.2±21.12) decreased compared with that of Ang II group(q=3.91, P < 0.05). However, the expression did not return to the level of control group, and there was significant difference between PD98059 group and control group(q =3.85, P < 0.05). Conclusion: The results indicate that angiotensin II promotes cardiac hypertrophy through inducing expression of PDGF receptor, in which mitogen activated protein kinase participates in. Maybe it is another important mechanism for Ang II-induced cardiac hypertrophy. The results can provide experimental data for the primary and secondary prevention in heart rehabilitation.

Angiotensin Ii Stimulates Protein Kinase D-Dependent Histone Deacetylase 5 Phosphorylation and Nuclear Export Leading to Vascular Smooth Muscle Cell Hypertrophy

Dectin-1 Acts As a Non-Classical Receptor of Ang II to Induce Cardiac Remodeling.

Macrophage Migration Inhibitory Factor in Hypothalamic Paraventricular Nucleus Neurons Decreases Blood Pressure in Spontaneously Hypertensive Rats

Inhibition of Histone Demethylase JMJD1C Attenuates Cardiac Hypertrophy and Fibrosis Induced by Angiotensin II

Protein Kinase D-dependent Phosphorylation and Nuclear Export of Histone Deacetylase 5 Mediates Vascular Endothelial Growth Factor-Induced Gene Expression and Angiogenesis.

Pressure Overload-Induced Cardiac Hypertrophy Response Requires Janus Kinase 2-Histone Deacetylase 2 Signaling.

Abstract 1357: PGC-1 Α As a Novel Regulator for Angiotensin II-induced Reactive Oxygen Species Production and Hypertrophy in Vascular Smooth Muscle Cells

Angiotensin Ii Promotes Smooth Muscle Cell Proliferation and Migration Through Release of Heparin-Binding Epidermal Growth Factor and Activation of Egf-Receptor Pathway

Mitochondrial K ATP channel-mediated autophagy contributes to angiotensin II-induced vascular dysfunction in mice

PGC-1 Alpha Serine 570 Phosphorylation and GCN5-mediated Acetylation by Angiotensin II Drive Catalase Down-Regulation and Vascular Hypertrophy.

The renin-angiotensin system and vascular hypertrophy

Abstract 374: Smooth Muscle Cell-specific Deletion Of At1a Receptor Attenuates Vascular Fibrosis In Angiotensin Ii-infused Mice

Role of Ras/PKCζ/MEK/ERK1/2 Signaling Pathway in Angiotensin II-induced Vascular Smooth Muscle Cell Proliferation

Redox-Sensitive Signaling by Angiotensin Ii Involves Oxidative Inactivation and Blunted Phosphorylation of Protein Tyrosine Phosphatase Shp-2 in Vascular Smooth Muscle Cells from Shr

DNA-dependent protein kinase catalytic subunit (DNA-PKcs) drives angiotensin II-induced vascular remodeling through regulating mitochondrial fragmentation

A Novel Mechanism of Angiotensin II‐induced Cardiac Hypertrophy – the Role of Soluble Epoxide Hydrolase

Src Tyrosine Kinase Regulates Angiotensin II-induced Protein Kinase Cζ Activation and Proliferation in Vascular Smooth Muscle Cells

DP1 (Prostaglandin D2 Receptor 1) Activation Protects Against Vascular Remodeling and Vascular Smooth Muscle Cell Transition to Myofibroblasts in Angiotensin II–Induced Hypertension in Mice

Essential Role Of Smad3 In Angiotensin Ii-Induced Vascular Fibrosis

Mechanism of cardiac hypertrophy: Effect of mitogen activated protein kinase inhibitor on expression of platelet-derived growth factor receptor induced by angiotensin II in cardiac myocytes

Angiotensin II-Induced Signal Transduction Mechanisms for Cardiac Hypertrophy